Abstract:Reactive oxygen species (ROS; superoxide, peroxide, and hydroxyl radical) are thought to contribute to the rapid bactericidal activity of diverse antimicrobial agents. The possibility has been raised that consumption of antioxidants in food may interfere with the lethal action of antimicrobials. Whether nutritional supplements containing antioxidant activity are also likely to interfere with antimicrobial lethality is unknown. To examine this possibility, resveratrol, a popular antioxidant dietary supplement, was added to cultures of Escherichia coli and Staphylococcus aureus that were then treated with antimicrobial and assayed for bacterial survival and the recovery of mutants resistant to an unrelated antimicrobial, rifampicin. Resveratrol, at concentrations likely to be present during human consumption, caused a 2- to 3-fold reduction in killing during a 2-hr treatment with moxifloxacin or kanamycin. At higher, but still subinhibitory concentrations, resveratrol reduced antimicrobial lethality by more than 3 orders of magnitude. Resveratrol also reduced the increase in reactive oxygen species (ROS) characteristic of treatment with quinolone (oxolinic acid). These data support the general idea that the lethal activity of some antimicrobials involves ROS. Surprisingly, subinhibitory concentrations of resveratrol promoted (2- to 6-fold) the recovery of rifampicin-resistant mutants arising from the action of ciprofloxacin, kanamycin, or daptomycin. This result is consistent with resveratrol reducing ROS to sublethal levels that are still mutagenic, while the absence of resveratrol allows ROS levels to high enough to kill mutagenized cells. Suppression of antimicrobial lethality and promotion of mutant recovery by resveratrol suggests that the antioxidant may contribute to the emergence of resistance to several antimicrobials, especially if new derivatives and/or formulations of resveratrol markedly increase bioavailability.

Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species

Cell Death from Antibiotics Without the Involvement of Reactive Oxygen Species

The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria

Reactive Oxygen Species Play a Dominant Role in All Pathways of Rapid Quinolone-Mediated Killing.

Post-stress Bacterial Cell Death Mediated by Reactive Oxygen Species.

Suppression of Reactive Oxygen Species Accumulation Accounts for Paradoxical Bacterial Survival at High Quinolone Concentration.

Moving Forward with Reactive Oxygen Species Involvement in Antimicrobial Lethality.

Membrane depolarization kills dormant Bacillus subtilis cells by generating a lethal dose of ROS

Generation of reactive oxygen species by lethal attacks from competing microbes.

Reactive Oxygen Species in Pathogen Clearance: the Killing Mechanisms, the Adaption Response, and the Side Effects.

The ratio of reactive oxygen and nitrogen species determines the type of cell death that bacteria undergo

Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria.

Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants

A review on oxidant and antioxidant effects of antibacterial agents: impacts on bacterial cell death and division and therapeutic effects or adverse reactions in humans

Reactive Oxygen Detoxification Contributes to Mycobacterium abscessus Antibiotic Survival

Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity

Mechanisms of Antibacterial Action of Quinoxaline 1,4-Di-n-oxides Against Clostridium Perfringens and Brachyspira Hyodysenteriae.

Antibiotic killing of drug-induced bacteriostatic cells

Role of reactive oxygen species in mechanisms of antimicrobial resistance in bacteria

Dimethyl Sulfoxide Protects Escherichia Coli From Rapid Antimicrobial-Mediated Killing

Synergistic Quinolone Sensitization by Targeting the recA SOS Response Gene and Oxidative Stress